Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma

Published:2023-06 Issue:6 Volume:5 Page:100747
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Pinato David J.^ORCID,Li Xiaoxue,Mishra-Kalyani Pallavi^ORCID,D’Alessio Antonio,Fulgenzi Claudia A.M.,Scheiner Bernhard^ORCID,Pinter Matthias^ORCID,Wei Guo,Schneider Julie^ORCID,Rivera Donna R.,Pazdur Richard,Theoret Marc R.,Casak Sandra^ORCID,Lemery Steven^ORCID,Fashoyin-Aje Lola,Cortellini Alessio^ORCID,Pelosof Lorraine

Funder

Cancer Research UK

Associazione Italiana per la Ricerca sul Cancro

Wellcome Trust

European Association for the Study of the Liver

NIHR Imperial Biomedical Research Centre

Cancer Treatment and Research Trust

Imperial Experimental Cancer Medicine Centre

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine

Reference48 articles.

1. New frontiers in the medical therapy of hepatocellular carcinoma;Fulgenzi;Chemotherapy,2022

2. Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: additional analyses from the phase III RESORCE trial;Finn;J Hepatol,2018

3. Evidence-based management of hepatocellular carcinoma: systematic review and meta-analysis of randomized controlled trials (2002–2020);Haber;Gastroenterology,2021

4. The hallmarks of successful anticancer immunotherapy;Galluzzi;Sci Transl Med,2018

5. Immunotherapies for hepatocellular carcinoma;Llovet;Nat Rev Clin Oncol,2022

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacomicrobiomics in precision cancer therapy: bench to bedside;Frontiers in Immunology;2024-09-09

2. Gut Microbiota, Deranged Immunity, and Hepatocellular Carcinoma;Biomedicines;2024-08-07

3. Therapeutic manipulation of the microbiome in liver disease;Hepatology;2024-06-26

4. The impact of antibiotic use in gastrointestinal tumors treated with immune checkpoint inhibitors: systematic review and meta-analysis;Frontiers in Medicine;2024-06-03

5. Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?;Seminars in Liver Disease;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3